Preliminary program Wednesday, November 25, 2026
Joseph Tintelnot (Universitätsklinikum Hamburg-Eppendorf, Germany)
Florence Renaud (Sorbonne University, France)
Christian Buchholz (Paul Ehrlich Institut, Germany)
Maurits Geerlings (NanoCell Thereapeutics, The Netherlands)